What happened
The S&P/ASX 200 Health Care Index jumped 3.76% over five trading days, leading all 11 market sectors while the benchmark S&P/ASX 200 fell 0.11% to 8,731.2 points. Key gainers included CSL Ltd, up 5.08% to $175.59, ResMed CDI up 5.15% to $31.87, and 4DMedical up 28.27% to $4.31.
Why it matters here
Healthcare shares have rallied 43% since hitting a nine-year low on June 3, significantly outperforming the broader market. Investors are rotating into high-quality growth and defensive healthcare names to protect capital while rate hikes threaten broader economic growth and cyclical equity returns.
What to watch
Upcoming annual general meeting trading updates, full-year profit results, and clinical trial disclosures from major ASX-listed healthcare holdings including CSL, ResMed, and Telix Pharmaceuticals.
Source
fool.com.au